A retrospective study analysing real-world experience of bictegravir/emtricitabine/tenofoviralafenamide (B/F/TAF) in a Scottish HIV cohort
Latest Information Update: 12 Nov 2020
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 12 Nov 2020 New trial record
- 08 Oct 2020 Results presented at the 15th International Congress on Drug Therapy and HIV Infection